Human ProIGF-I EA (92-105) antiserum was prepared by immunising rabbits with a 15 amino acid peptide derived from the E domain of human ProIGF-I EA linked to diphtheria toxoid. The peptide is located at the C terminus of the 153 amino acid ProIGF-I EA derived from alternative splicing of the human igf-1 gene. The antiserum recognises ProIGF-I EA but not ProIGF-I EB, ProIGF-I EC, mature IGF-I or IGF-II. Sequence analysis suggest it is likely to recognise ProIGF-I EA related proteins in a range of other species including non-human primates, rabbit, guinea-pig, dog, horse, sheep and goat but not rodents, due to alternative splicing of the igf-1 gene.
Human ProIGF-I EA (92 - 105) antiserum (Rabbit) specifications
Human ProIGF-I EA (92 - 105) antiserum (Rabbit) SDS
自1990年以来,GroPep Bioreagents便已向大学,研究机构,生物技术和制药公司的研究人员开发,制造和销售生长因子,抗体和相关蛋白试剂。
我们的任务是在准确和可靠的技术建议的支持下,为科学家提供高质量的试剂。
我们科学人员的强大研究背景和经验是我们为客户提供“动手”建议的关键。
我们了解我们的产品并倾听您的需求。
我们通过会议赞助和向会员提供折扣来支持IGF协会